Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 32,200 | 40,710 | 30,334 | 31,904 | 27,484 |
| Cost of Goods | 15,219 | 17,958 | 12,531 | 15,703 | 13,505 |
| Gross Profit | 16,981 | 22,752 | 17,803 | 16,201 | 13,979 |
| Operating Expenses | 33,188 | 22,680 | 30,061 | 34,798 | 35,960 |
| Operating Income | -15,988 | 1,030 | -11,727 | -17,894 | -21,476 |
| Interest Expense | 15,510 | 15,996 | 12,022 | 11,594 | 10,886 |
| Other Income | -560 | -4,202 | -926 | -728 | -307 |
| Pre-tax Income | -32,058 | -19,168 | -24,675 | -30,216 | -32,669 |
| Income Tax | -211 | 261 | 133 | 1,046 | 159 |
| Net Income Continuous | -31,847 | -19,429 | -24,808 | -31,262 | -32,828 |
| Net Income | $-31,847 | $-19,429 | $-24,808 | $-31,262 | $-32,828 |
| EPS Basic Total Ops | -1.67 | -1.01 | -1.32 | -1.67 | -1.76 |
| EPS Basic Continuous Ops | -1.67 | -1.02 | -1.32 | -1.67 | -1.76 |
| EPS Diluted Total Ops | -1.67 | -1.01 | -1.32 | -1.67 | -1.76 |
| EPS Diluted Continuous Ops | -1.67 | -1.02 | -1.32 | -1.67 | -1.76 |
| EPS Diluted Before Non-Recurring Items | -1.67 | -1.03 | -1.32 | -0.64 | -1.76 |
| EBITDA(a) | $-7,619 | $10,585 | $-4,924 | $-11,068 | $-14,709 |